Nephrol Dial Transplant (1996) 11: 498-506
© 1996 European Renal Association-European Dialysis and Transplant Association
research-article
Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis
Renal Unit, North Staffordshire Hospital Stoke-on-Trent, UK
Correspondence and offprint requests to: Correspondence and offprint requests to: Dr S. J. Davies, Department of Nephrology, Princes Road, Hartshill, Stoke-on-Trent ST4 7LN, UK
BACKGROUND.: Peritoneal infection and poor ultrafiltration continue to be the major causes of treatment failure in CAPD. The combined effects of peritonitis and the continuous exposure to dialysis fluid remain the most likely candidates affecting the peritoneum in the long term. The purpose of this study was to observe the effects of peritonitis and dialysis on longitudinal peritoneal function.
METHODS.: The peritoneal equilibration test (PET) was utilized to quantify longitudinal changes in low-molecular-weight solute transfer (D/Pcreat) and ultrafiltration (UF) in 233 patients treated with CAPD. Of these, 166 represented an unselected cohort (Group 1) studied prospectively from commencing treatment for up to 54 months, and 67 were selected patients (Group 2) with PET data available at commencement of the study, having been on dialysis for a minimum of 18 months. PETs were performed either 6-monthly or following peritonitis episodes.
RESULTS.: Data on the short-term effect of peritonitis kinetics were pooled for groups 1 and 2. Single, isolated episodes (n = 86) had no significant effect on D/Pcreat or UF, whereas recurrences or clusters of infection (n = 70) caused increases in D/Pcreat and reductions in UF, the significance of which increased with the number of episodes. There were significant correlations between both changes in D/Pcreat and UF with the cumulative dialysate leukocyte count, regardless of infecting organism, suggesting that intensity of peritoneal inflammation is also important. Those organisms associated with greater change in peritoneal kinetics, e.g. S. aureus, Pseudomonas, also had the highest neutrophil counts.
The longitudinal changes in peritoneal kinetics were analysed for patients in group 1 only. There was a highly significant increase in D/Pcreat after 6 months treatment; this increased further with time on treatment, reaching further significance at 42 and 48 months. There was an associated reduction in UF. In view of the short-term effects of peritonitis on kinetics group 1 was further subdivided into patients who were either peritonitis free or only experienced isolated infections, group 1a, and those that had multiple infection episodes, group 1b. Treatment drop-out, due to death or technical failure occurred at double the rate in group 1b, who also had significantly higher D/Pcreat and lower UF at 1, 6, 12, 18 and 24 months of treatment. Group 1a subsequently caught up, however, indicating that peritonitis is not the only factor influencing long-term changes in peritoneal kinetics.
CONCLUSIONS.: These data suggest that solute transfer increases and UF declines with time on peritoneal dialysis. This process is exacerbated and accelerated by peritonitis, and appears to be proportional to the degree of associated inflammation and number of infections in close proximity.
Keywords: continuous ambulatory peritoneal dialysis; peritonitis; ultrafiltration; solute transfer
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Kurata, S. Maruyama, S. Kato, W. Sato, J.-i. Yamamoto, T. Ozaki, A. Nitta, T. Nabeshima, Y. Morita, M. Mizuno, et al. Tissue-type plasminogen activator deficiency attenuates peritoneal fibrosis in mice Am J Physiol Renal Physiol, December 1, 2009; 297(6): F1510 - F1517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Miyamoto, M. Tamura, N. Kabashima, R. Serino, T. Shibata, Y. Furuno, M. Miyazaki, R. Baba, N. Sato, Y. Doi, et al. An integrin-activating peptide, PHSRN, ameliorates inhibitory effects of conventional peritoneal dialysis fluids on peritoneal wound healing Nephrol. Dial. Transplant., November 19, 2009; (2009) gfp601v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. W. Roberts, D. Baird, K. Gallagher, R. E. Jones, C. J. Pepper, J. D Williams, and N. Topley Functional Effector Memory T Cells Enrich the Peritoneal Cavity of Patients Treated with Peritoneal Dialysis J. Am. Soc. Nephrol., September 1, 2009; 20(9): 1895 - 1900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Perl, K. Huckvale, M. Chellar, B. John, and S. J. Davies Peritoneal Protein Clearance and not Peritoneal Membrane Transport Status Predicts Survival in a Contemporary Cohort of Peritoneal Dialysis Patients Clin. J. Am. Soc. Nephrol., July 1, 2009; 4(7): 1201 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Cueto-Manzano RAPID SOLUTE TRANSPORT IN THE PERITONEUM: PHYSIOLOGIC AND CLINICAL CONSEQUENCES Perit. Dial. Int., February 1, 2009; 29(Supplement_2): S90 - S95. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Power, N Duncan, and C Goodlad Advances and innovations in dialysis in the 21st century Postgrad. Med. J., February 1, 2009; 85(1000): 102 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Smit, M. M. Ho-dac-Pannekeet, and R. T. Krediet Treatment of severe ultrafiltration failure with nonglucose dialysis solutions in patients with and without peritoneal sclerosis NDT Plus, October 1, 2008; 1(suppl_4): iv63 - iv70. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Flessner Distributed model of peritoneal transport: implications of the endothelial glycocalyx Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2142 - 2146. [Full Text] [PDF]
|
|
|
|
|
|
H. Nishimura, Y. Ito, M. Mizuno, A. Tanaka, Y. Morita, S. Maruyama, Y. Yuzawa, and S. Matsuo Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1084 - F1093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Montenegro, R. Saracho, I. Gallardo, I. Martinez, R. Munoz, and N. Quintanilla Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1703 - 1708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Krediet 30 YEARS OF PERITONEAL DIALYSIS DEVELOPMENT: THE PAST AND THE FUTURE Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S35 - S41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-C. Szeto, K.-M. Chow, C. W.-K. Lam, C.-B. Leung, B. C.-H. Kwan, K.-Y. Chung, M.-C. Law, and P. K.-T. Li Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--A 1-year randomized control trial Nephrol. Dial. Transplant., February 1, 2007; 22(2): 552 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-J. F. Reyes, M.-A. Bajo, C. Hevia, G. del Peso, S. Ros, A. G. de Miguel, A. Cirugeda, M.-J. Castro, J. A. Sanchez-Tomero, and R. Selgas Inherent high peritoneal transport and ultrafiltration deficiency: their mid-term clinical relevance Nephrol. Dial. Transplant., January 1, 2007; 22(1): 218 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-C. Fang, C.-J. Yen, Y.-M. Chen, T.-S. Chu, M.-T. Lin, J.-Y. Yang, and T.-J. Tsai Diltiazem suppresses collagen synthesis and IL-1{beta}-induced TGF-{beta}1 production on human peritoneal mesothelial cells Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1340 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Brown Peritonitis: limiting the damage Nephrol. Dial. Transplant., August 1, 2005; 20(8): 1539 - 1541. [Full Text] [PDF]
|
|
|
|
|
|
G. del Peso, M. J. Fernandez-Reyes, C. Hevia, M. A. Bajo, M. J. Castro, A. Cirugeda, J. A. Sanchez-Tomero, and R. Selgas Factors influencing peritoneal transport parameters during the first year on peritoneal dialysis: peritonitis is the main factor Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1201 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Penders, T. Fiers, A. M. Dhondt, G. Claeys, and J. R. Delanghe Automated flow cytometry analysis of peritoneal dialysis fluid Nephrol. Dial. Transplant., February 1, 2004; 19(2): 463 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Hermsen, L. B. Hovde, J. R. Hotchkiss, and J. C. Rotschafer Increased Killing of Staphylococci and Streptococci by Daptomycin Compared with Cefazolin and Vancomycin in an In Vitro Peritoneal Dialysate Model Antimicrob. Agents Chemother., December 1, 2003; 47(12): 3764 - 3767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Davies, G. Woodrow, K. Donovan, J. Plum, P. Williams, A. C. Johansson, H.-P. Bosselmann, O. Heimburger, O. Simonsen, A. Davenport, et al. Icodextrin Improves the Fluid Status of Peritoneal Dialysis Patients: Results of a Double-Blind Randomized Controlled Trial J. Am. Soc. Nephrol., September 1, 2003; 14(9): 2338 - 2344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-H. Wang, C.-Y. Lin, and T.-P. Huang Patterns of CD4/CD8 T-cell ratio in dialysis effluents predict the long-term outcome of peritonitis in patients undergoing peritoneal dialysis Nephrol. Dial. Transplant., June 1, 2003; 18(6): 1181 - 1189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Margetts and D. N. Churchill Acquired Ultrafiltration Dysfunction in Peritoneal Dialysis Patients J. Am. Soc. Nephrol., November 1, 2002; 13(11): 2787 - 2794. [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Margetts, M. Kolb, L. Yu, C. M. Hoff, C. J. Holmes, D. C. Anthony, and J. Gauldie Inflammatory Cytokines, Angiogenesis, and Fibrosis in the Rat Peritoneum Am. J. Pathol., June 1, 2002; 160(6): 2285 - 2294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Fu{beta}holler, S. zur Nieden, B. Grabensee, and J. Plum Peritoneal Fluid and Solute Transport: Influence of Treatment Time, Peritoneal Dialysis Modality, and Peritonitis Incidence J. Am. Soc. Nephrol., April 1, 2002; 13(4): 1055 - 1060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Williams, K. J. Craig, N. Topley, C. Von Ruhland, M. Fallon, G. R. Newman, R. K. Mackenzie, and G. T. Williams Morphologic Changes in the Peritoneal Membrane of Patients with Renal Disease J. Am. Soc. Nephrol., February 1, 2002; 13(2): 470 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mortier, A. S. De Vriese, J. Van de Voorde, T. P. Schaub, J. Passlick-Deetjen, and N. H. Lameire Hemodynamic Effects of Peritoneal Dialysis Solutions on the Rat Peritoneal Membrane: Role of Acidity, Buffer Choice, Glucose Concentration, and Glucose Degradation Products J. Am. Soc. Nephrol., February 1, 2002; 13(2): 480 - 489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Jones, C. J. Holmes, R. K. Mackenzie, R. Stead, G. A. Coles, J. D. Williams, D. Faict, and N. Topley Continuous Dialysis with Bicarbonate/Lactate-Buffered Peritoneal Dialysis Fluids Results in a Long-Term Improvement in Ex Vivo Peritoneal Macrophage Function J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S97 - 103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Gokal Peritoneal Dialysis in the 21st Century: An Analysis of Current Problems and Future Developments J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S104 - 115. [Full Text] [PDF]
|
|
|
|
|
|
A. S. D. Vriese, S. Mortier, and N. H. Lameire Glucotoxicity of the peritoneal membrane: the case for VEGF Nephrol. Dial. Transplant., December 1, 2001; 16(12): 2299 - 2302. [Full Text] [PDF]
|
|
|
|
|
|
S. H. Chung, O. Heimburger, P. Stenvinkel, J. Bergstrom, and B. Lindholm Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis Nephrol. Dial. Transplant., November 1, 2001; 16(11): 2240 - 2245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. MARGETTS, M. KOLB, T. GALT, C. M. HOFF, T. R. SHOCKLEY, and J. GAULDIE Gene Transfer of Transforming Growth Factor-{beta}1 to the Rat Peritoneum: Effects on Membrane Function J. Am. Soc. Nephrol., October 1, 2001; 12(10): 2029 - 2039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. D. VRIESE, R. G. TILTON, C. C. STEPHAN, and N. H. LAMEIRE Vascular Endothelial Growth Factor Is Essential for Hyperglycemia-Induced Structural and Functional Alterations of the Peritoneal Membrane J. Am. Soc. Nephrol., August 1, 2001; 12(8): 1734 - 1741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Piillips, S. J. Davies, and E. White Health-related quality of life assessment in end-stage renal failure Journal of Research in Nursing, May 1, 2001; 6(3): 658 - 670. [Abstract] [PDF]
|
|
|
|
|
|
S. J. DAVIES, L. PHILLIPS, P. F. NAISH, and G. I. RUSSELL Peritoneal Glucose Exposure and Changes in Membrane Solute Transport with Time on Peritoneal Dialysis J. Am. Soc. Nephrol., May 1, 2001; 12(5): 1046 - 1051. [Abstract] [Full Text]
|
|
|
|
|
|
S. J. Davies Peritoneal solute transport--we know it is important, but what is it? Nephrol. Dial. Transplant., August 1, 2000; 15(8): 1120 - 1123. [Full Text] [PDF]
|
|